4/29/2024WuXi Wants to Regain Client Confidence Amid Claims of IP Transfer to C...

4/29/2024A US-China Pharma Drug War in the Making (Asia Times)

4/29/2024Key Considerations for Entering China's Healthcare Market

4/26/2024BMS and Cellares Collaboration: Navigating U.S.-China Biopharma Tensio...

4/26/2024China to Further Strengthen Community Medical Services

4/26/2024Novartis Witnesses Sharp Chinese Drug Sales Growth in Q1/2024

4/26/2024JPO Publicizes the Proposed Tender Selections for Renewed VBP for Insu...

4/26/2024Recent Executive Moves

4/26/2024Drug R&D and Product Registration News Digest April 2024 (4)

4/25/2024Sanofi to Expedite New Product Launches in China

4/25/2024Roche Unruffled by China Bill as It Looks to Grow Roots in the Region ...

4/24/2024NHC Issues Announcement on Jurisdiction of Human Genetic Resource Mana...

4/24/2024Review of Leading Class 1 New Drugs by Chinese Sales Value in 2023

4/23/2024NMPA Issues the Announcement on Relevant Matters Concerning the Optimi...

4/23/2024NMPA Issues Announcement on Further Strengthening the Drug Distributio...

4/23/2024Novartis Actively Evaluating Ties with Chinese Contractors Amidst US B...

4/23/2024Free Pricing in China for Highly Innovative Medicines (LinkedIn)

4/19/2024China's Drugmakers Can't Sell mRNA Shots But Haven't Quit Yet (Reuters...

4/19/2024How BIO CEO's Cozy Relationship with WuXi Soured (STAT)

4/19/2024Recent Executive Moves

4/19/2024Drug R&D and Product Registration News Digest April 2024 (3)

4/18/2024Andao Pharma/Kind Pharma and Fibrogen Settle on IP Dispute over HIF- P...

4/18/2024CDE Issues the Detailed Rules on Adding Pediatric Information to the P...

4/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (81...

4/17/2024NMPA Withdraws Approvals for 87 Drug Products

4/17/2024China Announces the 2024 Special Rectification Plan for Illegal Activi...

4/17/2024A Risky Bet: Zai Lab's Uncertain Future (Seeking Alpha)

4/16/2024America Hits Chinese Biotech — And Its Own Drugmakers (Economist)

4/16/2024NMPA Issues the List of Reference Formulations for GQCE Studies (79th ...

4/15/2024NHSA: Over 11M Chinese Benefited from Critical Illness Insurance

Page:10/718 Total number of articles:21530: [First][<<] [8] [9] [10] [11] [12] [>>] [End]